NCT02296645View on ClinicalTrials.gov

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Surgical Site Infection
Interventions
DRUG

ZuraPrep

Apply topically.

DRUG

ChloraPrep

Apply topically.

Trial Locations (1)

20164

MicroBioTest Laboratories, Sterling

All Listed Sponsors
lead

Zurex Pharma, Inc.

INDUSTRY

NCT02296645 - Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055) | Biotech Hunter | Biotech Hunter